These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 11162046
41. [Use of permanent magnets and magnetic fluids in experimental oncology]. Barybin AS, Reshchikov VP. Eksp Onkol; 1985; 7(4):18-22, 71. PubMed ID: 3930206 [Abstract] [Full Text] [Related]
42. Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate. Torchilin VP. Adv Drug Deliv Rev; 2005 Jan 02; 57(1):95-109. PubMed ID: 15518923 [Abstract] [Full Text] [Related]
43. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones. Workman P. Cancer Chemother Pharmacol; 2003 Jul 02; 52 Suppl 1():S45-56. PubMed ID: 12819933 [Abstract] [Full Text] [Related]
44. Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles. Ma HL, Qi XR, Ding WX, Maitani Y, Nagai T. J Biomed Mater Res A; 2008 Mar 01; 84(3):598-606. PubMed ID: 17618488 [Abstract] [Full Text] [Related]
45. Challenges in the development of magnetic particles for therapeutic applications. Barry SE. Int J Hyperthermia; 2008 Sep 01; 24(6):451-66. PubMed ID: 18608583 [Abstract] [Full Text] [Related]
46. Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity. Cabral H, Nishiyama N, Kataoka K. J Control Release; 2007 Aug 28; 121(3):146-55. PubMed ID: 17628162 [Abstract] [Full Text] [Related]
47. Polymer conjugates: nanosized medicines for treating cancer. Vicent MJ, Duncan R. Trends Biotechnol; 2006 Jan 28; 24(1):39-47. PubMed ID: 16307811 [Abstract] [Full Text] [Related]
48. High-gradient magnetic capture of ferrofluids: implications for drug targeting and tumor embolization. Babincová M, Babinec P, Bergemann C. Z Naturforsch C J Biosci; 2001 Jan 28; 56(9-10):909-11. PubMed ID: 11724405 [Abstract] [Full Text] [Related]
49. Liposomes for drug targeting in cancer chemotherapy. Liliemark J. Eur J Surg Suppl; 1991 May 28; (561):49-52. PubMed ID: 1720049 [No Abstract] [Full Text] [Related]
50. Strategy for the development of novel anticancer drugs. Saijo N, Tamura T, Nishio K. Cancer Chemother Pharmacol; 2003 Jul 28; 52 Suppl 1():S97-101. PubMed ID: 12856152 [Abstract] [Full Text] [Related]
51. A.S. Lübbe et al., Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res., 56: 4694-4701, 1996; and Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res., 56: 4686-4693, 1996. Gallo JM, Hafeli U. Cancer Res; 1997 Jul 15; 57(14):3063-5. PubMed ID: 9230223 [No Abstract] [Full Text] [Related]
52. Analytical model of magnetic nanoparticle transport and capture in the microvasculature. Furlani EP, Ng KC. Phys Rev E Stat Nonlin Soft Matter Phys; 2006 Jun 15; 73(6 Pt 1):061919. PubMed ID: 16906876 [Abstract] [Full Text] [Related]
53. [Physical basis for the application of ferromagnetics introduced into body]. Rymarchuk VI, Malenkov AG, Radkevich LA, Sarbash VI. Biofizika; 1990 Jun 15; 35(1):145-54. PubMed ID: 2189499 [Abstract] [Full Text] [Related]
56. [Controlled drug therapy with the preparations immobilized on magnetic microphores]. Derzhavin AE. Sov Med; 1988 Jun 15; (1):47-50. PubMed ID: 3283953 [No Abstract] [Full Text] [Related]